Rasio rega marang prakiraan pendapatan ainos.com (AIMD)

Ainos Corporation - logo grafis emiten AIMD

Ainos, Inc. (AIMD) is implementing AI algorithms for the instantaneous analysis of biomaterials to eliminate human error. The forward P/S trend reflects the dynamics of this automation, where the value of 899.50 serves as the current metric. Management is developing cloud monitoring and portable diagnostic systems. The strategy is based on B2B integration of patents into electronics, deliberately avoiding mergers and acquisitions.

AIMD Ainos: Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ing interval 28.04.2023 - 14.11.2026

Rincian metrik komprehensif lan analitis Ainos Corporation (AIMD)

- rega saiki lan proyeksi nilai saham:
Analisis komprehensif perusahaan:AIMD (Ainos)
Produk sing diprodhuksi Ainos Corporation

The integration of diagnostic platforms into pharmacy chains provides Ainos, Inc. (AIMD) with strategic access to the rapid testing market. The forward P/S ratio quantifies this expansion by comparing market capitalization with expected revenue to assess the premium paid for future growth. Low indicator values on this chart may suggest business maturity, whereas high values confirm market confidence in the issuer's technological potential.

Analisis pesaing Ainos, Inc.

Multiplikator Forward P/S A (Agilent)|Rasio kapitalisasi marang dodolan sing dikarepake Quest Diagnostics Inc. (DGX)|ILMN - Rasio rega marang prakiraan pendapatan|EXAS (Exact Sciences Inc.) - Kapitalisasi marang prakiraan pendapatan|Revvity, Inc. (RVTY) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep bio-rad.com (BIO)|Rasio rega marang prakiraan pendapatan Anbio|Sotera Health Corp (SHC) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan QDEL (QuidelOrtho Corp)|OPK (OPKO Health Corp.) - Rega forward marang dodolan|Multiplikator Forward P/S CDNA (CareDx, Inc)|Rasio kapitalisasi marang dodolan sing dikarepake maravai.com (MRVI)|FLGT - Rasio rega marang prakiraan pendapatan|LAB (Standard BioTools Inc) - Kapitalisasi marang prakiraan pendapatan|CTKB: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan OraSure Corp|Multiplikator forward rega marang pendapatan XGN|mdxhealth.com (MDXH) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S LUCD|Multiplikator Forward P/S prenetics.com (PRE)|Multiplikator Forward P/S IMDX (Insight Molecular Diagnostics Inc)|Rasio kapitalisasi marang dodolan sing dikarepake Trinity Biotech PLC (TRIB)|PRPH - Rasio rega marang prakiraan pendapatan|codiagnostics.com (CODX) - Multiplikator forward rega marang pendapatan|HSCS: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan BMRA|Rasio rega marang prakiraan pendapatan Cardio Diagnostics Holdings Inc.|Multiplikator forward rega marang pendapatan Onconetix Corporation (ONCO)|Multiplikator Forward P/S VRAX|BJDX - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S AWH (Aspira Women's Health Inc.)|AXDX: Kapitalisasi marang prakiraan pendapatan|centogene.com - Multiplikator Forward P/S|ENZ - Multiplikator Forward P/S|fresh2.co (FRES) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan GENE|ME (23andMe) - Multiplikator Forward P/S|Multiplikator Forward P/S Psychemedics Corp.